These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12506697)

  • 1. Analysis of gene expression in striatal tissue by multiprobe RNase protection assay.
    Richtand NM
    Methods Mol Med; 2003; 79():181-92. PubMed ID: 12506697
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of mRNA expression in striatal tissue by differential display polymerase chain reaction.
    Berke JD
    Methods Mol Med; 2003; 79():193-209. PubMed ID: 12506698
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of TaqMan RT-PCR for real-time semiquantitative analysis of gene expression in the striatum.
    Medhurst AD; Pangalos MN
    Methods Mol Med; 2003; 79():229-41. PubMed ID: 12506700
    [No Abstract]   [Full Text] [Related]  

  • 4. Loss of D2 receptors during aging is partially due to decreased levels of mRNA.
    Mesco ER; Joseph JA; Blake MJ; Roth GS
    Brain Res; 1991 Apr; 545(1-2):355-7. PubMed ID: 1830509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transcriptional regulation of loss of rat striatal D2 dopamine receptor during aging.
    Sakata M; Farooqui SM; Prasad C
    Brain Res; 1992 Mar; 575(2):309-14. PubMed ID: 1533340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in mRNA levels but not in the density of D2 dopamine receptors in rat striatum after transient forebrain ischemia.
    Benfenati F; Cimino M; Zoli M; Grimaldi R; Zini I; Agnati LF
    Neurosci Lett; 1991 May; 126(1):6-8. PubMed ID: 1830941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of D1 and D2 dopamine receptors and associated second messenger systems in fetal striatal transplants.
    Helm GA; Robertson MW; Jallo GI; Simmons N; Bennett JP
    Exp Neurol; 1991 Feb; 111(2):181-9. PubMed ID: 1703498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment.
    Coirini H; Schumacher M; Angulo JA; McEwen BS
    Eur J Pharmacol; 1990 Sep; 186(2-3):369-71. PubMed ID: 2127022
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased striatal D2 dopamine receptor mRNA synthesis during aging.
    Mesco ER; Carlson SG; Joseph JA; Roth GS
    Brain Res Mol Brain Res; 1993 Jan; 17(1-2):160-2. PubMed ID: 8381899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated reserpine increases striatal dopamine receptor and guanine nucleotide binding protein RNA.
    Butkerait P; Friedman E
    J Neurochem; 1993 Feb; 60(2):566-71. PubMed ID: 8419537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of prolactin receptor mRNA in the corpus striatum and substantia nigra of the rat.
    Pi X; Voogt JL; Grattan DR
    J Neurosci Res; 2002 Feb; 67(4):551-8. PubMed ID: 11835322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum.
    Le Moine C; Bloch B
    J Comp Neurol; 1995 May; 355(3):418-26. PubMed ID: 7636023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies.
    Bal A; Bachelot T; Savasta M; Manier M; Verna JM; Benabid AL; Feuerstein C
    Brain Res Mol Brain Res; 1994 May; 23(3):204-12. PubMed ID: 8057777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Stepholidine promotes proliferation and neuronal differentiation of rat embryonic striatal precursor cells in vitro.
    Guo H; Yu Y; Xing L; Jin GZ; Zhou J
    Neuroreport; 2002 Nov; 13(16):2085-9. PubMed ID: 12438931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia.
    Meador-Woodruff JH; Haroutunian V; Powchik P; Davidson M; Davis KL; Watson SJ
    Arch Gen Psychiatry; 1997 Dec; 54(12):1089-95. PubMed ID: 9400344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two forms of the rat D2 dopamine receptor as revealed by the polymerase chain reaction.
    Rao DD; McKelvy J; Kebabian J; MacKenzie RG
    FEBS Lett; 1990 Apr; 263(1):18-22. PubMed ID: 2139615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems.
    Mansour A; Meador-Woodruff JH; Camp DM; Robinson TE; Bunzow J; Van Tol H; Civelli O; Akil H; Watson SJ
    Prog Clin Biol Res; 1990; 328():227-30. PubMed ID: 2106148
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiprobe RNase protection assay with internally labeled radioactive probes, generated by RT-PCR and nested PCR.
    von Wolff M; Tabibzadeh S
    Front Biosci; 1999 Jul; 4():C1-3. PubMed ID: 10393129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of universal conditions for duplex quantitative reverse transcription polymerase chain reaction assays.
    Ishii T; Sootome H; Shan L; Yamashita K
    Anal Biochem; 2007 Mar; 362(2):201-12. PubMed ID: 17257573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontogenetic expression of D2 dopamine receptor mRNA in rat corpus striatum.
    Chen JF; Weiss B
    Brain Res Dev Brain Res; 1991 Nov; 63(1-2):95-104. PubMed ID: 1665109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.